Additional Registration and Fee Required

The following programming requires an additional registration fee. Special programs are in-person only.

Hypertrophic Cardiomyopathy Medical Society, HCMS Scientific Sessions
Friday, November 6, 2026, 6:30 a.m. – 6:45 p.m.
This focused program brings together leading physicians, researchers, and healthcare professionals dedicated to advancing the science and care of hypertrophic cardiomyopathy (HCM). This event showcases cutting-edge clinical research and fosters collaboration and education.

Innovation Forum ^{NEW for 2026}
Friday, November 6, 2026, 9:00 a.m. - 6:00 p.m.
The American Heart Innovation Forum is a one-day, high-energy experience designed to help clinicians, scientists, and innovators turn ideas into impact. Through candid conversations with founders, investors, and industry leaders, participants will explore the real-world path from discovery to startup across cardiovascular and brain health. Explore agenda and more.

Cardiovascular-Kidney-Metabolic (CKM) Symposium ^{NEW for 2026}
Friday, November 6, 2026, 1:00 – 5:00 p.m.
This half-day program provides clinicians with practical, guideline-informed strategies for the prevention and management of cardiovascular-kidney-metabolic (CKM) syndrome following the release of the first AHA/ACC clinical practice guideline. Through targeted lectures and interactive case-based sessions, participants will learn to apply CKM staging, risk assessment, and coordinated care principles in real-world practice.

Obesity Summit ^{NEW for 2026}
Monday, November 9, 2026, 8:00 a.m. – 10:00 a.m.
Join leading experts for a focused two-hour summit exploring obesity as a critical and modifiable driver of cardiovascular, kidney, and metabolic disease. Attendees will gain actionable insights to optimize treatment approaches, enhance patient engagement, and improve outcomes across the continuum.

Included with In-Person #ScientificSessions26 Registration

The following offerings will be available on a first-come, first-served basis. Space is limited. When you register, select which events you plan to attend.
Special Programs are in-person only.

QCOR at Sessions
Friday, November 6, 2026, 8:00 a.m. – 5:00 p.m.
The QCOR at Scientific Sessions 2026 is a 1-day program that will be of interest to clinicians, researchers, medical students and trainees, nurses, pharmacists, administrators, healthcare and managed care professionals, policymakers, and other professionals interested in the quality of care and outcomes research in cardiovascular disease and stroke.

Bioengineering in Cardiovascular Health BCVS Symposium
Friday, November 6, 2026, 9:45 a.m.–4:15 p.m.
This cutting-edge 4-part symposium highlights breakthroughs driving the future of cardiac repair and regeneration, from molecular discovery to patient care. Featuring leaders in cardiovascular biology, RNA science, and bioengineering, the program explores targeted regenerative strategies, advanced delivery platforms, RNA-based mechanisms and engineering, and novel technologies—including engineered tissues, smart biomaterials, and AI-enabled therapy design. Spanning basic, translational, and clinical science, showcasing how innovative approaches are accelerating the journey from bench to bedside. With strong scientific impact and global representation, it serves as a model for inclusive, forward-looking cardiovascular research.

Heart/Kidney Symposium
Friday, November 6, 2026, 9:45 a.m. – 12:45 p.m.
The Heart-Kidney Symposium will spotlight novel therapeutic targets to lower cardiovascular risk in individuals with chronic kidney disease, including inflammation, eicosanoid signaling, potassium homeostasis, and metabolic reprogramming. Additionally, the Symposium will discuss the cardiovascular implications of emerging therapies in chronic kidney disease.

Early Career
Friday, November 6, 2026, 11:00 a.m. - 6:00 p.m.
The American Heart Association is committed to the next generation of clinicians and researchers by offering programs to facilitate your career growth and development. If you are a student, trainee, fellow or are early in your career this is designed for you.

From Discovery to Delivery: Translating Cardiovascular Innovation into Scalable Global Impact
Friday, November 6 – Monday, November 9, 2026
Global Impact sessions explore how breakthrough cardiovascular science moves from discovery to real-world implementation across diverse health systems and geographies. Building on the Main Event program, these sessions look at cardiovascular innovation through a global health lens, with a focus on collaboration, access, equity and sustainable impact.

Attendees will hear from global leaders and partners about scalable approaches that can help improve cardiovascular outcomes around the world. The program includes the prestigious Paul Dudley White International Lecture, delivered by Patrick W. Serruys, MD, PhD, along with a distinguished lineup of speakers representing the American Heart Association’s global partners.

Genomic and Precision Medicine Symposium: Cardiovascular Gene Therapy
Friday, November 6, 2026, 1:15 p.m. – 6:00 p.m.
Gene therapies for genetic cardiovascular disease have been approved by the FDA for a subset of conditions, and several more are in clinical trials. These therapies hold enormous promise for precision medicine, but optimization of therapies (delivery and cargo), clinical implementation strategies, and communication between stakeholders remain critical issues that deserve robust discussion. This GPM Symposium aims to provide a forum for those discussions, during which cardiologists and trainees across the spectrum of genetics knowledge can learn from academic and industry experts at the leading edge of this field.

Congenital Heart Disease Summit ^{NEW for 2026}
Monday, November 9, 2026, 8:00 a.m. – 1:00 p.m.
Congenital heart disease (CHD) affects 1 in 100 births and demands lifelong, coordinated care. This summit highlights how evidence, advocacy, and innovation can drive meaningful change in pediatric and congenital heart care.

Through expert-led talks, attendees will learn how to shape policy, advance device development, and leverage strategic communication for greater impact. Participants will also gain practical insights into the device development pathway, from concept to market, including FDA regulatory processes. A multidisciplinary panel will explore collaboration strategies that foster innovation while maintaining CME integrity. Walk away with actionable tools to improve outcomes across your institution and community.